|Articles|April 1, 2012
- Applied Clinical Trials-04-01-2012
- Volume 21
- Issue 4
Applied Clinical Trials Digital Edition - April 2012
INFORMATION TECHNOLOGY : Enhancing Risk Assessment and Mitigation REGULATORY : Sunshine Act?s Impact on the Industry Implementation of Objective Internal Monitoring Also in this issue : Impact of Transparency Policies, EMA?s Executive Director Faces Multiple Challenges, The Roles of Healthcare and Research, HIV Vaccine Trials
Advertisement
Articles in this issue
over 13 years ago
Business and News Update April 2012over 13 years ago
Transparency, Sunshine Shape Researchover 13 years ago
When Worlds Collide: Healthcare and Researchover 13 years ago
CRO Founded to Address Neglected Diseases in Under Served Countriesover 13 years ago
EFGCP Acts to Reduce Ethics Problemsover 13 years ago
Sunshine Act's Impactover 13 years ago
Keeping a Cool Head Amidst Turmoilover 13 years ago
Startup Offers New Take on Recruitmentover 13 years ago
Risk Assessment and MitigationNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
2
Using Global Patient Data to Design Smarter, More Inclusive Clinical Trials
3
ACT Brief: AI Expands Global Site Leadership as Ozempic Shows Potential to Reverse Biological Age
4
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
